Why did Clean Science and Technology (CLEAN) stock move recently?

On 9/2/2026, Clean Science and Technology moved +4.4% — No clear company-specific catalyst identified in today's coverage or recent filings; the move appears to reflect broader sector or market sentiment. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Clean Science and Technology (CLEAN) overvalued or fairly valued?

MarketChacha shows Clean Science and Technology's valuation in context — a forward P/E of about 23.8, a price-to-book of about 5.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Clean Science and Technology's revenue?

Clean Science and Technology reported revenue of ₹815 Cr for FY2026, with net profit of ₹251 Cr, per official filings.

What is the share price of Clean Science and Technology (CLEAN)?

Clean Science and Technology last traded at ₹759.85 (-3.1% on the day), as of 10/19/2026 — a delayed quote shown for education, not investment advice.

Clean Science and Technology

CLEAN · NSE · Chemicals · India

Snapshot

TickerCLEAN

ExchangeNSE

SectorChemicals

IndustrySpecialty Chemicals

CountryIndia

Employees396

HeadquartersPune, India

Websitecleanscience.co.in

Filings tracked6

About Clean Science and Technology

Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the United States, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, ascorbyl palmitate, tertiary butyl hydroquinone, hydroquinone, hindered amine light stabilisers, catechol, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which includes dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It serves acrylic monomers and polymers; animal nutrition and feed; coatings, resins, paints, and inks; cosmetic and personal care; electronics and electronic chemicals; edible oils; flavors and fragrances; food and beverages; fuel, lubricants, and industrial fluids; nutraceuticals and dietary supplements; petrochemicals; peptide and fine chemicals synthesis; pharmaceuticals intermediates; plastics; rubber and elastomers; light/UV stabilizers; and water treatment industries. The company was incorporated in 2003 and is headquartered in Pune, India.

Who owns it

Promoters55.2%
Institutions23.7%
Public & other21.1%

51 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 7.5 points over the period — profitability is trending down.

Net margin trend31.5% → 24.0%

Margin has compressed by about 7.5 points over the period — profitability is trending down.

Growth qualityrev 1% · PAT -6%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹272 Cr · EPS 13.20

Est. earnings growth +205.6%

Next fiscal year

Rev ₹1,511 Cr · EPS 31.98

Est. earnings growth +27.0%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹957 Cr

Net margin

24.0%

Revenue CAGR (3y)

+0.7%

Profit CAGR (3y)

-8.0%

Net profit (FY2026)

₹230 Cr

Ask MarketChacha about CLEAN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Sep 2, 2026
No clear company-specific catalyst identified in today's coverage or recent filings; the move appears to reflect broader sector or market sentiment.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹957 Cr	₹230 Cr	24.0%
FY2025	₹967 Cr	₹264 Cr	27.4%
FY2024	₹791 Cr	₹244 Cr	30.8%
FY2023	₹936 Cr	₹295 Cr	31.5%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹268 Cr	₹73 Cr	27.3%
Q4 FY26	₹249 Cr	₹58 Cr	23.4%
Q3 FY26	₹220 Cr	₹46 Cr	20.9%
Q2 FY26	₹245 Cr	₹55 Cr	22.7%
Q1 FY26	₹243 Cr	₹70 Cr	28.8%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Dividend Updates
Enclosed is the shareholder approved the final dividend of Rs. 4 per share for FY26
BSE9/12/2026
Change in Directorate
Enclosed is the Appointment of Mr. Krishnakumar Saboo as Wholetime Director.
BSE9/12/2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Enclosed is the Scrutinizer''s Report for the 23rd Annual General Meeting
BSE9/12/2026material
Shareholder Meeting / Postal Ballot-Outcome of AGM
Enclosed is the Outcome of 23rd Annual General Meeting held on 12.09.2026.
BSE9/12/2026material
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosed are the details for strategic long-term supply arrangement with Kemin Industries.
BSE8/1/2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosed are the details.
BSE7/30/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.